Tenax Therapeutics (TENX) Gains from Sales and Divestitures (2013 - 2019)
Tenax Therapeutics' (TENX) quarterly Gains from Sales and Divestitures came in at $12195.0 in Q4 2019, down 67.41% year-on-year from $37420.0 in Q4 2018, and little changed quarter-over-quarter from $12195.0 in Q3 2019.
Tenax Therapeutics (TENX) Gains from Sales and Divestitures (2013 - 2019) Analysis & Trends
Tenax Therapeutics has disclosed Gains from Sales and Divestitures across 7 years of filings, most recently posting $12195.0 for Q4 2019.
- Gains from Sales and Divestitures for Q4 2019 came in at $12195.0, down 67.41% year-over-year; the trailing twelve-month figure through Dec 2019 was $12195.0 (down 67.41% YoY), and the FY2019 annual result was $12195.0, down 67.41% from the prior year.
- Gains from Sales and Divestitures came in at $12195.0 for Q4 2019 at Tenax Therapeutics, roughly flat from $12195.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $116525.0 in Q2 2017 to a low of $16.0 in Q4 2016.
- The 5-year median for Gains from Sales and Divestitures is $12195.0 (2019), against an average of $31087.9.
- Across the five-year window, Gains from Sales and Divestitures plunged 90.8% in 2016 and jumped 151163.64% in 2017, its largest moves.
- Tenax Therapeutics' Gains from Sales and Divestitures stood at $174.0 in 2015, then slumped by 90.8% to $16.0 in 2016, then soared by 36387.5% to $5838.0 in 2017, then soared by 540.97% to $37420.0 in 2018, then slumped by 67.41% to $12195.0 in 2019.
- The last three Gains from Sales and Divestitures figures came in at $12195.0 (Q4 2019), $12195.0 (Q3 2019), and $12195.0 (Q2 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Tenax Therapeutics | 120.33 Mn | 120.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 12,195.00 |
| Dec 31, 2019 | 12,195.00 |
| Sep 30, 2019 | 12,195.00 |
| Sep 30, 2019 | 12,195.00 |
| Jun 30, 2019 | 12,195.00 |
| Jun 30, 2019 | 12,195.00 |
| Mar 31, 2019 | 12,195.00 |
| Mar 31, 2019 | 12,195.00 |
| Dec 31, 2018 | 37,420.00 |
| Dec 31, 2018 | 37,420.00 |
| Sep 30, 2018 | 37,420.00 |
| Sep 30, 2018 | 37,420.00 |
| Jun 30, 2018 | 25,600.00 |
| Jun 30, 2018 | 25,600.00 |
| Mar 31, 2018 | 25,600.00 |
| Mar 31, 2018 | 25,600.00 |
| Dec 31, 2017 | 5,838.00 |
| Dec 31, 2017 | 5,838.00 |
| Sep 30, 2017 | 116,525.00 |
| Sep 30, 2017 | 116,525.00 |